Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장준 | * |
dc.date.accessioned | 2024-02-01T16:30:48Z | - |
dc.date.available | 2024-02-01T16:30:48Z | - |
dc.date.issued | 2024 | * |
dc.identifier.issn | 2666-3791 | * |
dc.identifier.other | OAK-34788 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/266925 | - |
dc.description.abstract | Repeated pandemics caused by the influenza virus and severe acute respiratory syndrome coronavirus (SARS-CoV) have resulted in serious problems in global public health, emphasizing the need for broad-spectrum antiviral therapeutics against respiratory virus infections. Here, we show the protective effects of longacting recombinant human interleukin-7 fused with hybrid Fc (rhIL-7-hyFc) against major respiratory viruses, including influenza virus, SARS-CoV-2, and respiratory syncytial virus. Administration of rhIL-7-hyFc in a therapeutic or prophylactic regimen induces substantial antiviral effects. During an influenza A virus (IAV) infection, rhIL-7-hyFc treatment increases pulmonary T cells composed of blood -derived interferon g (IFNg)+ conventional T cells and locally expanded IL -17A+ innate -like T cells. Single -cell RNA transcriptomics reveals that rhIL-7-hyFc upregulates antiviral genes in pulmonary T cells and induces clonal expansion of type 17 innate -like T cells. rhIL-7-hyFc-mediated disease prevention is dependent on IL -17A in both IAVand SARS-CoV-2-infected mice. Collectively, we suggest that rhIL-7-hyFc can be used as a broadly active therapeutic for future respiratory virus pandemic. | * |
dc.language | English | * |
dc.publisher | CELL PRESS | * |
dc.title | Fc-fused IL-7 provides broad antiviral effects against respiratory virus infections through IL-17A-producing pulmonary innate-like T cells | * |
dc.type | Article | * |
dc.relation.issue | 1 | * |
dc.relation.volume | 5 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.journaltitle | CELL REPORTS MEDICINE | * |
dc.identifier.doi | 10.1016/j.xcrm.2023.101362|http://dx.doi.org/10.1016/j.xcrm.2023.101362 | * |
dc.identifier.wosid | WOS:001170323100001 | * |
dc.identifier.scopusid | 2-s2.0-85182580227 | * |
dc.author.google | Kwon, Dong-il | * |
dc.author.google | Park, Subin | * |
dc.author.google | Jeong, Yujin L. | * |
dc.author.google | Kim, Young-Min | * |
dc.author.google | Min, Jeongyong | * |
dc.author.google | Lee, Changhyung | * |
dc.author.google | Choi, Jung-ah | * |
dc.author.google | Choi, Yoon Ha | * |
dc.author.google | Kong, Hyun-Jung | * |
dc.author.google | Choi, Youngwon | * |
dc.author.google | Baek, Seungtae | * |
dc.author.google | Lee, Kun-Joo | * |
dc.author.google | Kang, Yeon-Woo | * |
dc.author.google | Jeong, Chaerim | * |
dc.author.google | You, Gihoon | * |
dc.author.google | Oh, Youngsik | * |
dc.author.google | Im, Sun-Kyoung | * |
dc.author.google | Song, Manki | * |
dc.author.google | Kim, Jong Kyoung | * |
dc.author.google | Chang, Jun | * |
dc.author.google | Choi, Donghoon | * |
dc.author.google | Lee, Seung-Woo | * |
dc.contributor.scopusid | 장준(8735999100) | * |
dc.date.modifydate | 20240502144901 | * |